Literature DB >> 6152615

The influence of H2 receptor antagonists on the plasma concentrations of midazolam and temazepam.

P Elliott, J W Dundee, R J Elwood, P S Collier.   

Abstract

This study shows that 1 day's treatment with cimetidine or ranitidine causes a raised relative systemic availability of orally administered midazolam (p less than 0.01), but pretreatment with a common emulsion antacid does not alter bioavailability. Temazepam bioavailability after oral administration is unchanged after either H2 receptor antagonist, or after the emulsion antacid. The difference in the systemic availability of the two benzodiazepines following pretreatment with either cimetidine or ranitidine may be explained by inhibition of the mixed function oxidase system in the liver. Drugs with a relatively high liver extraction ratio, such as midazolam, are likely to be affected to a greater extent than those with a low extraction ratio, such as temazepam. The clinical relevance of these findings is yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6152615

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  9 in total

Review 1.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 3.  Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.

Authors:  Nina Isoherranen; Justin D Lutz; Sophie P Chung; Houda Hachad; Rene H Levy; Isabelle Ragueneau-Majlessi
Journal:  Chem Res Toxicol       Date:  2012-09-27       Impact factor: 3.739

Review 4.  Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.

Authors:  S R Smith; M J Kendall
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

Review 5.  Pharmacokinetics of the newer benzodiazepines.

Authors:  P D Garzone; P D Kroboth
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

6.  The influence of particle size on the bioavailability of inhaled temazepam.

Authors:  J P Fee; P S Collier; A P Launchbury; R S Clarke
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

7.  General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.

Authors:  Yoshiyuki Ohno; Akihiro Hisaka; Hiroshi Suzuki
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.

Authors:  Akihiro Hisaka; Makiko Kusama; Yoshiyuki Ohno; Yuichi Sugiyama; Hiroshi Suzuki
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

9.  Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans.

Authors:  Annika Elbe; Kathrin Isabelle Foerster; Antje Blank; Peter Rose; Jürgen Burhenne; Walter Emil Haefeli; Gerd Mikus
Journal:  Eur J Clin Pharmacol       Date:  2022-03-03       Impact factor: 3.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.